Advances in Gynecologic Oncology

Advances in Gynecologic Oncology PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Advances in Gynecologic Oncology: Transforming Cancer Care for Women
Gynecologic oncology has seen remarkable advancements in recent years, revolutionizing the way cancers of the female reproductive system are diagnosed, treated, and managed. This presentation, “Advances in Gynecologic Oncology,” highlights key innovations that are improving outcomes and quality of life for women worldwide.
Discover cutting-edge developments such as minimally invasive surgeries, including robotic-assisted procedures, which reduce recovery time and improve precision. Learn about the impact of targeted therapies like PARP inhibitors and anti-angiogenic agents, and explore the promise of immunotherapy in tackling treatment-resistant cancers.
Advancements in genetic testing have paved the way for personalized treatment plans, while technologies like AI and liquid biopsies are enhancing early detection and monitoring. Fertility-sparing options and improvements in radiation therapy also play a crucial role in ensuring holistic care for women.
This presentation also addresses global challenges in accessibility and the ongoing efforts to bridge gaps in gynecologic oncology care. By integrating technology, research, and patient-centered approaches, the field continues to push the boundaries of innovation.
Join us to understand how these breakthroughs are shaping the future of gynecologic oncology and improving survival rates and patient well-being.

Tags : Gynecologic oncology, cancer treatment, ovarian cancer, cervical cancer, targeted therapy, immunotherapy, AI in oncology, minimally invasive surgery

Published on : Dec 03, 2024 | Views : 40 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Advances in Gynecologic Oncology Innovations in Diagnosis, Treatment, and Patient Care Dr. Vineeta Bose Oncologist & Hematologist
Slide 2-

Why Innovation Matters in Gynecologic Oncology Gynecologic cancers (cervical, ovarian, endometrial, vulvar, and vaginal) are a significant health burden. Advances in treatment and technology improve survival rates and patient outcomes. Focus areas: Precision medicine, minimally invasive surgery, targeted therapies, and immunotherapy. Reference: World Health Organization (WHO). (2021). Cancer Fact Sheet.
Slide 3-

Advances in Screening and Diagnosis HPV Testing: More accurate than Pap smear in detecting cervical cancer. Liquid Biopsies: Non-invasive tests to detect circulating tumor DNA. AI in Imaging: Artificial intelligence for enhanced accuracy in diagnosing ovarian and endometrial cancers. Use of biomarkers (e.g., CA-125 for ovarian cancer). Reference: Schiffman, M., et al. (2018). Cervical-cancer screening with HPV testing. New England Journal of Medicine, 379(20), 1950-1958.
Slide 4-

Revolutionizing Surgery for Gynecologic Cancers Minimally Invasive Surgery (MIS): Laparoscopy and robotic-assisted surgery for precision and quicker recovery. Cytoreductive Surgery: Advanced techniques for debulking in ovarian cancer. Sentinel lymph node mapping for precise staging and reduced morbidity. Reference: Bogani, G., et al. (2020). Minimally invasive surgery in gynecologic cancers. Journal of Gynecologic Oncology, 31(2), e54.
Slide 5-

Targeted Therapy Personalized Medicine in Gynecologic Oncology PARP inhibitors for BRCA-mutated ovarian cancer (e.g., Olaparib, Niraparib). Anti-angiogenic therapies (e.g., Bevacizumab) to block tumor blood supply. HER2-targeted therapy in uterine serous carcinoma. Reference: Moore, K., et al. (2018). Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. New England Journal of Medicine, 379(26), 2495-2505.
Slide 6-

Immunotherapy in Gynecologic Cancers Checkpoint inhibitors (e.g., Pembrolizumab, Nivolumab) in recurrent cervical cancer. Tumor-infiltrating lymphocyte (TIL) therapy: Experimental treatment for advanced gynecologic cancers. Role of PD-1/PD-L1 inhibitors in immunotherapy. Reference: Lheureux, S., et al. (2019). Immunotherapy in gynecologic cancers. Current Oncology Reports, 21(10), 45.
Slide 7-

Advances in Radiation Therapy Intensity-Modulated Radiation Therapy (IMRT): High precision with fewer side effects. Image-Guided Radiation Therapy (IGRT): Improved targeting for cervical and endometrial cancers. Brachytherapy advancements for cervical and vaginal cancers. Reference: Small, W., et al. (2017). Advances in radiation therapy for gynecologic cancers. Gynecologic Oncology, 144(3), 577-584.
Slide 8-

AI and Machine Learning in Gynecologic Oncology Enhanced imaging diagnostics (e.g., pattern recognition in ultrasound and MRI). Predictive models for treatment outcomes. Workflow optimization in clinical trials and patient management. Reference: Erickson, B. J., et al. (2020). Artificial intelligence in oncology: Current applications and future perspectives. Journal of Clinical Oncology, 38(8), 1361-1371.
Slide 9-

Fertility-Sparing Techniques Radical trachelectomy for early-stage cervical cancer. Ovarian transposition to protect ovarian function during radiation. Cryopreservation of oocytes or embryos before chemotherapy. Reference: Oktay, K., et al. (2018). Fertility preservation in gynecologic oncology. Obstetrics & Gynecology, 131(1), 16-26.
Slide 10-

Advances in Genetic Testing BRCA1/BRCA2 testing for ovarian cancer risk. Lynch syndrome screening for endometrial cancer. Risk-reducing surgeries for mutation carriers (e.g., prophylactic oophorectomy). Reference: Moller, P., et al. (2020). Risk-reducing salpingo-oophorectomy in BRCA mutation carriers. Journal of Clinical Oncology, 38(13), 1403-1409.
Slide 11-

Emerging Therapies and Clinical Trials The Future of Gynecologic Oncology Ongoing trials for novel immunotherapies and PARP inhibitors. CAR-T cell therapy under investigation for gynecologic malignancies. Role of nanotechnology in drug delivery systems. Reference: ClinicalTrials.gov. (2023). Gynecologic cancer clinical trials database.
Slide 12-

Conclusion Advances in screening, treatment, and precision medicine have transformed gynecologic oncology. Multidisciplinary approaches ensure personalized care. Continued innovation and research are key to improving survival and quality of life.
Slide 13-

Thank You